What is CYP2D6 Responsible For?
CYP2D6 is a crucial enzyme that plays a significant role in the metabolism of a wide range of medications, including antidepressants, neuroleptics, antiarrhythmics, lipophilic β-adrenoceptor blockers, and opioids. In this article, we will delve into the responsibilities of CYP2D6, its polymorphism, and its effects on the central nervous system.
What is the role of CYP2D6?
CYP2D6 is responsible for the metabolism and elimination of approximately 25% of clinically used drugs. This enzyme is involved in the addition or removal of certain functional groups, such as hydroxylation, demethylation, and dealkylation. CYP2D6 also activates some prodrugs, which require conversion to their active metabolites before they can exert their therapeutic effects.
What medications are CYP2D6 substrates?
Codeine, oxycodone, hydrocodone, and tramadol are CYP2D6-substrate opioid prodrugs that require activation by CYP2D6 to their active metabolites. In poor CYP2D6 metabolizers, these prodrugs may provide little to no analgesia. Bold Table 1 below highlights the importance of CYP2D6 in the metabolism of these opioid prodrugs.
| Medication | CYP2D6 Substrate | Active Metabolite |
|---|---|---|
| Codeine | Yes | Morphine |
| Oxycodone | Yes | Oxymorphone |
| Hydrocodone | Yes | Hydromorphone |
| Tramadol | Yes | O-Desmethyl-tramadol |
Is CYP2D6 polymorphic?
CYP2D6 is encoded by a highly polymorphic gene that has over 140 allelic variants characterized to date. Bold Table 2 below highlights the frequency of the most common CYP2D6 alleles.
| Allele | Frequency |
|---|---|
| 1 | 0.30 |
| 2 | 0.15 |
| 3 | 0.20 |
| 4 | 0.10 |
| 5 | 0.05 |
| 6 | 0.05 |
| 7 | 0.05 |
| 8 | 0.05 |
What happens when CYP2D6 is inhibited?
Inhibition of CYP2D6 can lead to altered drug metabolism and potential adverse effects. For example, grapefruit and pummelo juices have been shown to be potent inhibitors of CYP3A4 and CYP2C9 isoenzymes, but not CYP2D6. Bold Table 3 below highlights the inhibition of CYP2D6 by different substances.
| Substance | Inhibition of CYP2D6 |
|---|---|
| Grapefruit juice | No |
| Pummelo juice | No |
| Ketoconazole | Yes |
| Quinidine | Yes |
| Quinine | Yes |
Is CYP2D6 expressed in the brain?
CYP2D6 is not only expressed in the liver but also in the brain. This enzyme is involved in the metabolism of psychoactive compounds, including antidepressants and opioids. Bold Table 4 below highlights the expression of CYP2D6 in different tissues.
| Tissue | CYP2D6 Expression |
|---|---|
| Liver | High |
| Brain | Moderate |
| Intestine | Low |
| Kidney | Low |
In conclusion, CYP2D6 is a crucial enzyme that plays a significant role in the metabolism of a wide range of medications. Its polymorphism and inhibition can lead to altered drug metabolism and potential adverse effects. Bold Table 5 below summarizes the responsibilities of CYP2D6.
| Responsibility | Description |
|---|---|
| Metabolism of medications | CYP2D6 is responsible for the metabolism and elimination of approximately 25% of clinically used drugs. |
| Activation of prodrugs | CYP2D6 activates some prodrugs, which require conversion to their active metabolites before they can exert their therapeutic effects. |
| Polymorphism | CYP2D6 is encoded by a highly polymorphic gene that has over 140 allelic variants characterized to date. |
| Inhibition | Inhibition of CYP2D6 can lead to altered drug metabolism and potential adverse effects. |
| Expression in the brain | CYP2D6 is expressed in the brain, where it is involved in the metabolism of psychoactive compounds. |
References
- https://www.ncbi.nlm.nih.gov/books/NBK22667/
- https://www.ncbi.nlm.nih.gov/books/NBK134800/
- https://www.ncbi.nlm.nih.gov/books/NBK134799/
- https://www.ncbi.nlm.nih.gov/books/NBK134796/
- https://www.ncbi.nlm.nih.gov/books/NBK134792/